MAGGI, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 20.067
AS - Asia 8.135
EU - Europa 6.398
SA - Sud America 2.274
Continente sconosciuto - Info sul continente non disponibili 691
AF - Africa 195
OC - Oceania 11
Totale 37.771
Nazione #
US - Stati Uniti d'America 19.575
SG - Singapore 3.048
IT - Italia 2.189
BR - Brasile 1.830
VN - Vietnam 1.703
CN - Cina 1.350
HK - Hong Kong 1.233
IE - Irlanda 884
SE - Svezia 602
DE - Germania 590
FR - Francia 541
RU - Federazione Russa 395
UA - Ucraina 375
GB - Regno Unito 358
CA - Canada 200
AR - Argentina 184
FI - Finlandia 169
BD - Bangladesh 157
IN - India 132
MX - Messico 112
ID - Indonesia 105
JP - Giappone 93
EC - Ecuador 73
IQ - Iraq 59
ZA - Sudafrica 51
NL - Olanda 50
CO - Colombia 49
PL - Polonia 42
PY - Paraguay 40
ES - Italia 39
AT - Austria 32
UZ - Uzbekistan 32
CL - Cile 31
NG - Nigeria 30
PK - Pakistan 28
CR - Costa Rica 27
MA - Marocco 27
VE - Venezuela 26
JM - Giamaica 25
TR - Turchia 25
HN - Honduras 24
BE - Belgio 22
SA - Arabia Saudita 22
LT - Lituania 21
PE - Perù 21
GT - Guatemala 19
TT - Trinidad e Tobago 19
EG - Egitto 18
KE - Kenya 18
NP - Nepal 16
NI - Nicaragua 14
PH - Filippine 14
UY - Uruguay 14
MY - Malesia 13
AZ - Azerbaigian 12
CZ - Repubblica Ceca 12
DZ - Algeria 12
TN - Tunisia 12
MD - Moldavia 11
AE - Emirati Arabi Uniti 10
IL - Israele 10
JO - Giordania 10
BB - Barbados 9
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
LB - Libano 9
AU - Australia 8
BG - Bulgaria 8
ET - Etiopia 8
OM - Oman 8
EU - Europa 7
HR - Croazia 7
PR - Porto Rico 7
RO - Romania 7
SV - El Salvador 7
EE - Estonia 6
PT - Portogallo 6
TH - Thailandia 6
AL - Albania 5
CI - Costa d'Avorio 5
CW - ???statistics.table.value.countryCode.CW??? 5
BO - Bolivia 4
DK - Danimarca 4
GP - Guadalupe 4
HU - Ungheria 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
BZ - Belize 3
CU - Cuba 3
CY - Cipro 3
GA - Gabon 3
GE - Georgia 3
GR - Grecia 3
LK - Sri Lanka 3
PA - Panama 3
QA - Qatar 3
TZ - Tanzania 3
AM - Armenia 2
Totale 37.053
Città #
San Jose 2.517
Ashburn 2.053
Singapore 1.524
Council Bluffs 1.357
Fairfield 1.289
Hong Kong 1.223
Jacksonville 961
Milan 944
Dublin 864
Princeton 737
Dallas 729
Chandler 652
Wilmington 641
Woodbridge 491
The Dalles 472
Houston 450
Nyköping 438
Seattle 429
Boardman 414
Cambridge 381
Ho Chi Minh City 378
Lauterbourg 370
Chicago 334
Dong Ket 334
Beijing 329
Los Angeles 287
New York 218
Santa Clara 216
Phoenix 209
Hanoi 197
São Paulo 184
San Diego 181
Redwood City 176
Rome 160
Ogden 142
Ann Arbor 138
Washington 135
Helsinki 128
Salt Lake City 117
London 108
Naples 101
Tokyo 86
Buffalo 79
Como 70
Tampa 67
Mexico City 66
Elk Grove Village 59
Munich 58
Haiphong 57
Frankfurt am Main 56
Atlanta 54
Rio de Janeiro 53
Lancaster 50
Guangzhou 48
Norwalk 48
Orem 47
Toronto 47
Brasília 46
Brooklyn 42
Da Nang 42
San Francisco 42
Catania 40
Varese 40
Denver 39
Montreal 37
Warsaw 36
Shanghai 35
Belo Horizonte 32
Miami 32
Chennai 30
Abuja 29
Nuremberg 29
Biên Hòa 28
Porto Alegre 28
Shenzhen 28
Tashkent 27
Stockholm 26
Dhaka 25
North Bergen 25
Sterling 25
Curitiba 24
Hangzhou 24
Baghdad 23
Guarulhos 23
Johannesburg 23
Boston 22
Campinas 22
Ninh Bình 22
Poplar 22
Bologna 21
Quito 21
Turku 21
Guayaquil 20
San José 20
Brussels 19
Falkenstein 19
Manchester 19
Moscow 19
Ribeirão Preto 19
Salvador 19
Totale 25.138
Nome #
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy 490
Torque Teno Virus: A Promising Biomarker in Kidney Transplant Recipients 305
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19 271
Previous humoral immunity to the endemic seasonal alphacoronaviruses NL63 and 229E is associated with worse clinical outcome in COVID-19 and suggests original antigenic sin 243
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy 232
Viral hepatitis 222
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 221
Torque Teno virus: any pathological role in liver transplanted patients? 204
Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples 193
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age 191
Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9 188
Tyrosine kinase inhibitors play an antiviral action in patients affected by chronic myeloid leukemia: a possible model supporting their use in the fight against SARS-CoV-2 185
An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children 179
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation 178
Impact of Microbial Metabolites on Microbiota–Gut–Brain Ax-is in Inflammatory Bowel Disease 177
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 175
Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates 173
Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection 172
Immunobiology of the Torque teno viruses and other anelloviruses 170
An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine 167
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients 160
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients 154
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease 152
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022 150
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 150
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine 141
How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection 141
Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+NaiVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study 140
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy 140
Enhanced in vitro virus expression using 3-dimensional cell culture spheroids for infection 139
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy 139
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients 136
Hyaluronan: A neuroimmune modulator in the microbiota-gut axis 136
TTV GUIDE IT - A randomised controlled trial to compare the safety, tolerability and preliminary efficacy between standard and torque teno virus-guided immunosuppression in stable adult kidney transplant recipients with low immunological risk in the first year after transplantation - a trial protocol 135
La vaccinazione con la glicoproteina B del virus Herpes Simplex tipo 1 protegge contro l’herpes genitale 134
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 134
High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabs 133
Absence of xenotropic murine leukemia virus-related virus in italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis 132
HIV-1 NAT minipool during the pre-seroconversion window period: Detection of a repeat blood donor 132
Sialic acid moieties and 5-HT2a: two faces of the same receptor for JC virus? 131
Asymptomatic SARS-CoV-2 vaccine breakthrough infections in health care workers identified through routine universal surveillance testing 131
Zika Virus: Implications for Public Health 130
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 126
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy 125
Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon? 124
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients 124
TTV and other anelloviruses: The astonishingly wide spread of a viral infection 123
Detection of Torquetenovirus and Redondovirus DNA in Saliva Samples from SARS-CoV-2-Positive and -Negative Subjects 123
Sialic acid moieties and 5-HT(2a): Two faces of the same receptor for JC virus? 123
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus (TTV) viremia, the new surrogate marker of immune competence 123
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022 122
Analysis of immune escape variants from antibody‐based therapeutics against covid‐19: A systematic review 122
Anelloviruses and immune competence 120
Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy 120
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: Old drugs for an old disease 119
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 118
Immunosuppressive monoclonal antibodies: current and next generation 116
Human anelloviruses and the central nervous system 116
TT virus in the nasal secretions of children with acute respiratory diseases: Relations to viremia and disease severity 115
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022–2023 114
Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects 114
Small anellovirus in hepatitis C patients and healthy controls 114
Assessment of prevalence and load of torquetenovirus viremia in a large cohort of healthy blood donors 114
Torquetenovirus infection and ciliary dysmotility in children with recurrent pneumonia 113
A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers 113
A novel rolling circle amplification assay to detect members of the family Anelloviridae in pigs and humans 113
JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis 111
Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon alpha 111
Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy 111
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution 110
Attempt to classify the clinical impact of DNA viruses according to the ability to activate the innate immune system 109
TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases 109
In vitro sensitivity of human metapneumovirus to type i interferons 108
Performance Assessment of the LIAISON® SARS-CoV-2 Antigen Assay On Nasopharyngeal Swabs 108
Anellovirus 107
Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022–2023 106
Getting the most from the Ebola vaccine success 106
TT virus infection of periodontal tissues: A controlled clinical and laboratory pilot study 106
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease 106
Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients 106
COVID-19 emergency management: From the reorganization of the endoscopy service to the verification of the reprocessing efficacy 106
Anellovirus 105
Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans 105
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes 105
5-HT2a antagonists as a new treatment for JCV-associated progressive multifocal leukoencephalopathy 103
Expression of MxA mRNA in PBL from chronic hepatitis C patients and response to interferon-alpha therapy 103
High prevalence of TT virus viremia in Italian patients, regardless of age, clinical diagnosis, and previous interferon treatment 103
Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders 103
Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients 103
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 103
In vivo MxA mRNA expression as predictive marker of response to IFN alpha in chronic active hepatitis C patients 102
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation 102
Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients 102
Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine 102
The Virome and its Major Component, Anellovirus, a Convoluted System Molding Human Immune Defenses and Possibly Affecting the Development of Asthma and Respiratory Diseases in Childhood 101
Anellovirus 101
Cell therapies for treatment of human immunodeficiency virus infection 101
Preemptive valganciclovir for cytomegalovirus infection in hematological patients 101
Role of Hematopoietic Cells in the Maintenance of Chronic Human Torquetenovirus Plasma Viremia 101
Human bocavirus in Italian patients with respiratory diseases 100
Totale 13.826
Categoria #
all - tutte 219.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.228 0 0 0 113 52 129 181 231 165 574 297 486
2022/20232.586 442 148 149 151 81 638 30 256 370 195 58 68
2023/20242.847 233 234 256 569 574 483 49 79 216 46 17 91
2024/20255.308 19 39 885 102 64 381 98 166 624 375 811 1.744
2025/202613.890 669 800 1.411 2.889 731 357 2.449 980 1.709 894 600 401
2026/20274.728 328 840 1.920 1.640 0 0 0 0 0 0 0 0
Totale 37.771